HC Wainwright & Co. Reiterates Buy on Coya Therapeutics, Maintains $18 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.7%

Neg 0% Neu 90.7% Pos 0%

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 price target.